Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02023060

Enrollment

100

Registered

2013-12-30

Start date

2013-11-30

Completion date

2030-11-30

Last updated

2023-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis, Trans Catheter Aortic Valve

Brief summary

The objective is to observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.

Detailed description

To observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 110 Years

Healthy volunteers

Inclusion criteria

1. Subject selected for transcatheter heart valve replacement 2. Signed informed consent to participate in the study

Exclusion criteria

1. Inability to sign written informed consent. 2. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).

Design outcomes

Primary

Measure	Time frame	Description
Clinical outcome of patients undergoing transcatheter valve replacement	12 months	Mortality, change in New York Heart Association class, change in ejection fraction.

Countries

Israel

Contacts

Primary ContactIsrael Barbash, MD

+97235305273

Outcome results